Future Uncertain For Gamida Despite Omisirge Optimism

Gamida Cell's Omisirge made it to the US market at the end of last year but despite a better-than-expected launch, the Israeli group has been forced to explore strategic alternatives to survive.

Lifeline
• Source: Shutterstock

More from Strategy

More from Business